0006-5029 : Verquvo 5 mg Oral Tablet, Film Coated
| NDC: | 0006-5029 |
| Labeler: | Merck Sharp & Dohme Corp. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Verquvo |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA214377 |
| Rev. Date: |
NDC Package Codes:
- 0006-5029-01: 14 TABLET, FILM COATED IN 1 BOTTLE (0006‑5029‑01)
- 0006-5029-02: 30 TABLET, FILM COATED IN 1 BOTTLE (0006‑5029‑02)
- 0006-5029-04: 10 BLISTER PACK IN 1 CARTON (0006‑5029‑04) > 10 TABLET, FILM COATED IN 1 BLISTER PACK (0006‑5029‑03)
- 0006-5029-05: 14 TABLET, FILM COATED IN 1 BOTTLE (0006‑5029‑05)
- 0006-5029-06: 1 BOTTLE IN 1 CARTON (0006‑5029‑06) / 14 TABLET, FILM COATED IN 1 BOTTLE (0006‑5029‑05)
Active Ingredients:
- Vericiguat
Dosage Strength:
- 5 mg
Pharmaceutical Classes:
- Guanylate Cyclase Stimulators [MoA]
- Soluble Guanylate Cyclase Stimulator [EPC]
Related Products:
Based on records with the same trade name.- 0006-5028 Verquvo 2.5 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
- 0006-5030 Verquvo 10 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0006-5028Next: 0006-5030 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.